Biohit Oyj announced unaudited consolidated earnings results for the first quarter ended March 31, 2012. For the quarter, the company reported loss of EUR 0.9 million or EUR 0.4 per diluted share on net sales of EUR 0.4 million compared to loss of EUR 1.5 million or EUR 0.0 per diluted share on net sales of EUR 0.4 million reported in the same period last year. Operating loss was EUR 1.1 million against EUR 0.9 million and loss before taxes was EUR 0.9 million against EUR 1.4 million reported last year. Net cash used in operating activities was EUR 0.7 million against net cash flow from operating activities of EUR 0.6 million reported last year. Net sales from continuing operations in 2012 is expected to improve from 2011. According to the company's estimate, it will achieve a positive result during 2013.